TNDM – tandem diabetes care, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

TNDM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/21

04:11 pm

tndm

Tandem Diabetes Care Announces Upcoming Conference Presentations [Yahoo! Finance]

Medium Report

Tandem Diabetes Care Announces Upcoming Conference Presentations [Yahoo! Finance]

Report

11/21

04:05 pm

tndm

Tandem Diabetes Care Announces Upcoming Conference Presentations

Medium Report

Tandem Diabetes Care Announces Upcoming Conference Presentations

Report

11/8

01:44 pm

tndm

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Barclays PLC from $58.00 to $60.00. They now have an "overweight" rating on the stock.

Low Report

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Barclays PLC from $58.00 to $60.00. They now have an "overweight" rating on the stock.

Report

11/8

09:58 am

tndm

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket [Yahoo! Finance]

Medium Report

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket [Yahoo! Finance]

Report

11/8

05:39 am

tndm

Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report [Yahoo! Finance]

Medium Report

Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report [Yahoo! Finance]

Report

11/7

02:34 pm

tndm

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $57.00 to $56.00. They now have a "buy" rating on the stock.

Low Report

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $57.00 to $56.00. They now have a "buy" rating on the stock.

Report

11/7

01:41 pm

tndm

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Robert W. Baird from $39.00 to $37.00. They now have a "neutral" rating on the stock.

Low Report

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Robert W. Baird from $39.00 to $37.00. They now have a "neutral" rating on the stock.

Report

11/7

02:31 am

tndm

Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]

Low Report

Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/6/2024

04:05 pm

tndm

tandem diabetes care, inc.

BEAT Report

-2.9%

tandem diabetes care, inc.

Report

8/1/2024

04:05 pm

tndm

tandem diabetes care, inc.

BEAT Report

18.3%

tandem diabetes care, inc.

Report

5/2/2024

04:05 pm

tndm

tandem diabetes care, inc.

BEAT Report

22.3%

tandem diabetes care, inc.

Report

2/21/2024

04:05 pm

tndm

tandem diabetes care, inc.

MISS Report

10.9%

tandem diabetes care, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/8

01:13 pm

Maintains

Overweight

Barclays

Low

Report

-0.7%

Report

11/8

01:13 pm

Maintains

Overweight

Barclays

Low

Report

-0.7%

Report

11/7

01:43 pm

Maintains

Buy

Canaccord Genuity

Low

Report

-2.0%

Report

11/7

12:46 pm

Maintains

Neutral

Baird

Low

Report

-2.2%

Report

11/7

12:46 pm

Maintains

Neutral

Baird

Low

Report

-2.2%

Report

11/6

08:06 am

Initiates

Outperform

Bernstein

Low

Report

-0.3%

Report

11/6

08:06 am

Initiates

Outperform

Bernstein

Low

Report

-0.3%

Report

11/6

07:32 am

Initiates

Outperform

Sanford C. Bernstein

Low

Report

0.7%

Report

Date

Time

Symbol

Headline

Impact

11/21

11:23 am

tndm

Form 144 TANDEM DIABETES CARE Filed by: BLICKENSTAFF KIM D

Low Report

Form 144 TANDEM DIABETES CARE Filed by: BLICKENSTAFF KIM D

Report

11/20

04:53 pm

tndm

Form 144 TANDEM DIABETES CARE Filed by: BLICKENSTAFF KIM D

Low Report

Form 144 TANDEM DIABETES CARE Filed by: BLICKENSTAFF KIM D

Report

11/19

05:23 pm

tndm

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Sheridan John F

Medium Report

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Sheridan John F

Report

11/19

05:23 pm

tndm

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Morrison Susan

Medium Report

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Morrison Susan

Report

11/19

05:23 pm

tndm

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Hansen Shannon Marie

Medium Report

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Hansen Shannon Marie

Report

11/19

05:23 pm

tndm

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Vosseller Leigh

Medium Report

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Vosseller Leigh

Report

11/19

05:23 pm

tndm

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Novara Mark David

Medium Report

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Novara Mark David

Report

11/19

05:23 pm

tndm

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Carpenter Rick

Medium Report

Form 4 TANDEM DIABETES CARE For: Nov 15 Filed by: Carpenter Rick

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.